FCMI

Foresite Capital Management IV Portfolio holdings

AUM $124M
1-Year Est. Return 24.36%
This Quarter Est. Return
1 Year Est. Return
-24.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$288M
AUM Growth
+$66.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1
+$16.3M
2
+$12.4M
3
+$8.63M
4
ABUS icon
Arbutus Biopharma
ABUS
+$8.52M
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$4.99M

Top Sells

1
+$20.8M
2
+$13.6M
3
+$4.35M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$2.39M
5
CBAY
Cymabay Therapeutics
CBAY
+$1.19M

Sector Composition

1 Healthcare 89.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$42.6M 14.52%
1,800,587
+1,362
2
$33.6M 11.47%
851,200
3
$29.2M 9.94%
1,231,543
+158,271
4
$28.1M 9.58%
565,755
+173,800
5
$27.2M 9.26%
2,023,369
-88,500
6
$26M 8.86%
61,903
+29,663
7
$22.6M 7.69%
721,903
+521,903
8
$19.4M 6.6%
2,651,825
+1,166,580
9
$18M 6.13%
270,424
-204,995
10
$17.9M 6.09%
1,130,919
+300,000
11
$10.6M 3.6%
529,551
+100,000
12
$4.99M 1.7%
+245,082
13
$3.61M 1.23%
295,000
-355,000
14
$2.24M 0.76%
+75,000
15
$1.64M 0.56%
+94,477
16
$403K 0.14%
10,650
-549,423
17
– –
-9,355
18
– –
-450,000